Tuesday, April 19, 2016

Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure (NYSE:LLY)

Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.